Literature DB >> 3965096

Use and limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer.

K M Erbil, J D Jones, G G Klee.   

Abstract

Concentrations of total serum N-acetyl-neuraminic acid (NANA) by high-performance liquid chromatography (HPLC) and lipid-bound sialic acid (LSA) by resorcinol procedure were evaluated and compared to carcinoembryonic antigen (CEA) as markers for colorectal carcinoma. Elevated concentrations of NANA were found in 32% of patients with nonmalignant disorders, 28% of patients with localized cancer, and 87% of patients with metastatic cancer. All three markers correlated with the extent of metastasis of colorectal carcinoma. Strong correlation was found between NANA and LSA measurements, whereas measurement of the sialic acid markers provide information that can not be derived from the measurement of CEA. NANA and LSA show promise as supplemental markers for staging and monitoring colorectal cancer, but they are neither sensitive nor specific enough for cancer screening.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965096     DOI: 10.1002/1097-0142(19850115)55:2<404::aid-cncr2820550219>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Effect of lead on serum sialic acids and proteins resistant to perchloric acid in rats.

Authors:  A B Patel; H Venkatakrishna-Bhatt
Journal:  Bull Environ Contam Toxicol       Date:  1992-04       Impact factor: 2.151

Review 2.  Serum sialylation changes in cancer.

Authors:  Zejian Zhang; Manfred Wuhrer; Stephanie Holst
Journal:  Glycoconj J       Date:  2018-04-21       Impact factor: 2.916

3.  Axillary versus peripheral blood levels of sialic acid, ferritin, and CEA in patients with breast cancer.

Authors:  M Monti; S Catania; E Locatelli; R Gandini; A Reggiani; E Cunietti
Journal:  Breast Cancer Res Treat       Date:  1990-12       Impact factor: 4.872

4.  Changes in ganglioside contents, plasma sialic acid and cAMP levels in experimental hepatoma in mice.

Authors:  C Q Lu; J Lu; B L Wang; Y Z Cui
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

5.  Plasma lipid-bound sialic acid alterations in neoplastic diseases.

Authors:  C Dwivedi; M Dixit; R E Hardy
Journal:  Experientia       Date:  1990-01-15

6.  Elevation of ratio of urinary N-acetylneuraminlactose to free sialic acid in some advanced cancer patients.

Authors:  I Shimada; M Shoji; R Futatsuya; T Katoh; Y Kominato; T Sakamoto; T Fujikura
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

7.  Preparation of N-acetylneuraminic acid from delipidated egg yolk.

Authors:  M Koketsu; L R Juneja; H Kawanami; M Kim; T Yamamoto
Journal:  Glycoconj J       Date:  1992-04       Impact factor: 2.916

8.  Serum glycoconjugates and ceruloplasmin in cancer of uterine cervix.

Authors:  Sharmila Upadhya; Subramanya Upadhya; K S Prabhu
Journal:  Indian J Clin Biochem       Date:  2002-01

9.  Total sialic acid, total protein and total sugar levels in serum and saliva of oral squamous cell carcinoma patients: A case control study.

Authors:  Nidhi Dhakar; Madhusudan Astekar; Mahesh Jain; Swati Saawarn; Nisheeth Saawarn
Journal:  Dent Res J (Isfahan)       Date:  2013-05

10.  Salivary lipid peroxidation and total sialic acid levels in smokers and smokeless tobacco users as Maraş powder.

Authors:  Naciye Kurtul; Engin Gökpınar
Journal:  Mediators Inflamm       Date:  2012-04-23       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.